Latest filing published 12 Jul 2023 for Sensei Biotherapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Samuel Broder: trading record in brief
All filings by Samuel Broder on record concern Faeth Therapeutics, Inc., in the capacity of board member. Over a trading history stretching from 10 June 2022 to 10 July 2023, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 12 July 2023 with a share grant in Faeth Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Samuel Broder
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,466 shares0Common StockSEC:0001209191-23-042101:0
- 4,466 shares0Common StockSEC:0001209191-22-036666:0
2 of 2 declarations
